The Myelodysplastic Syndromes Channel is supported with funding from Geron (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BSH 2022 | Genetic predispositions to MDS
Daniel Wiseman, MBChB, MRCP, FRCPath, PhD, University of Manchester, Manchester, UK, discusses genetic predispositions to myelodysplastic syndromes (MDS). A growing number of mutations associated with the development of MDS are being identified, including RUNX1, DDX41, and ETV6. It is important for clinicians to consider this genetic risk, and take the family history of every patient in order to examine the risk of a genetic predisposition. This interview took place at the 62nd Annual Scientific Meeting of the British Society for Haematology (BSH) 2022, in Manchester, UK.
Disclosures
Aster – received funding
